The Troponin I value was significantly lower in the USAP group than the STEMI and NSTEMI groups (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: Signal peptide complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor-like domain-containing protein 1 (SCUBE1) has been used in research as a biomarker in acute coronary syndrome (ACS).
📊
Key Findings & Data:The aim of this study is to determine if SCUBE1 and routine laboratory parameters are effective in distinguishing the patients presenting with clinical symptoms of unstable angina pectoris (USAP) from the patients who have non-ST-segment elevated myocardial infarction (NSTEMI) and non-cardiac chest pain patients (NCCP).Materials and Methods: The study group consisted of patients having chest pain or those suspected of having an ACS complaint.
💡
Conclusion & Impact:The Troponin I value was significantly lower in the USAP group than the STEMI and NSTEMI groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: Signal peptide complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor-like domain-containing protein 1 (SCUBE1) has been used in research as a biomarker in acute coronary syndrome (ACS). The aim of this study is to determine if SCUBE1 and routine laboratory parameters are effective in distinguishing the patients presenting with clinical symptoms of unstable angina pectoris (USAP) from the patients who have non-ST-segment elevated myocardial infarction (NSTEMI) and non-cardiac chest pain patients (NCCP).Materials and Methods: The study group consisted of patients having chest pain or those suspected of having an ACS complaint. The study consisted of 5 groups of 185 patients with USAP, NSTEMI, segment elevation myocardial infarction (STEMI), or NCCP, and a control group of 45 healthy patients (CG). The study was conducted according to the American Heart Association (AHA) guidelines.Results: There was no statistical difference between the patient groups and CG in terms of SCUBE1 (p=0.650). The Troponin I value was significantly lower in the USAP group than the STEMI and NSTEMI groups (p
🔖
Cite This Article
ÖZER, Ö. F., GÜLEN, B., SÖNMEZ, E., ÖZDEMİR, S., KESKİN, M., ÖZKAN, A., MUHARREM, N. (2022). The Diagnostic Value of SCUBE1 in Unstable Angina Pectoris Patients. Eurasian Journal of Emergency Medicine, Cilt: 15 - Sayı: 4, 167–171. https://ajindex.com/articles/508145
Bassand J-P, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernán- dez-Avilés F, et al. Guidelines for the diagnosis and treatment of non- ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-660. [CrossRef] Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unsta- ble angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062. [CrossRef] Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac tropo- nin testing. Clin Chem 2001; 47: 377-9.
Dai DF, Thajeb P, Tu CF, Chiang FT, Chen CH, Yang RB, et al. Plasma con- centration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J Am Coll Cardiol 2008; 51: 2173-80. [CrossRef] Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Cir- culation 2007; 116: e95-8. [CrossRef] Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syn- drome. Clin Chem 2008; 54: 723-8. [CrossRef] Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial in- jury in a preliminary evaluation using a new troponin I assay with im- proved sensitivity. Am J Clin Pathol 2007; 128: 282-6. [CrossRef] Parkash O, Almas A, Hameed A, Islam M. Comparison of non cardiac chest pain (NCCP) and acute coronary syndrome (ACS) patients present- ing to a tertiary care center. J Pak Med Assoc 2009; 59: 667-71.
Sonmez E, Turkdogan KA, Karabacak M, Civelek C, Yilmaz C, Ozer OF, et al. The diagnostic role of signal peptide-C1r/C1s, Uegf, and Bmp1-epi- dermal growth factor domain-containing protein 1 in non-ST-elevation acute coronary syndrome. Am J Emerg Med 2015; 33: 21-4. [CrossRef] Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitiv- ity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coro- nary syndrom